MT-ND5 and Leigh syndrome: Genetic testing using next-generation sequencing of mitochondrial DNA identified a pathogenic variant in MT-ND5 (m.13513G>A) with 95% heteroplasmy, confirming the diagnosis of mitochondrial DNA-associated Leigh syndrome.